Cardiac amyloidosis: an emerging target in HFpEF?

HFA Premium Access

Cardiac amyloidosis: an emerging target in HFpEF?

Session: Reshaping the future of heart failure management - Translating innovations to practice in HFpEF

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Speaker: Professor P. Van Der Meer (Groningen, NL)

Organised by PACE-CME - Physicians' Academy for Cardiovascular Education, supported with educational grants provided by Novartis, Novo Nordisk and Pfizer

Event: Heart Failure 2019

Congress Presentation

Add to my library

About the speaker

Professor Peter Van Der Meer

University Medical Centre Groningen, Groningen (Netherlands (The))

57 presentations

4 followers

5 more presentations in this session

Introduction - Reshaping the future of heart failure management - Translating innovations to practice in HFpEF.

Speaker: Professor R. De Boer (Rotterdam, NL) Professor D. van Veldhuisen (Groningen, NL)

Access

HFpEF: one name, many diseases, a wide variety?

Speaker: Professor A. Voors (Groningen, NL)

Access

Understanding and managing obesity-related HFpEF.

Speaker: Professor M. Packer (Dallas, US)

Access

Heart failure & diabetes: what is the goal of treatment?

Speaker: Professor J. McMurray (Glasgow, GB)

Access

Panel discussion - Reshaping the future of heart failure management - Translating innovations to practice in HFpEF.

Speaker: Professor R. De Boer (Rotterdam, NL) Professor D. van Veldhuisen (Groningen, NL)

Access

Access the full session

Reshaping the future of heart failure management - Translating innovations to practice in HFpEF

Speakers: Professor P. Van Der Meer, Professor R. De Boer, Professor D. van Veldhuisen, Professor A. Voors, Professor M. Packer...

Access

About the event

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources